Summers, Barbara D.
Kim, Kihwan
Clement, Cristina C.
Khan, Zohaib
Thangaswamy, Sangeetha
McCright, Jacob
Maisel, Katharina
Zamora, Sofia
Quintero, Stephanie
Racanelli, Alexandra C.
Redmond, David
D’Armiento, Jeanine
Yang, Jisheng
Kuang, Amy
Monticelli, Laurel
Kahn, Mark L.
Choi, Augustine M. K.
Santambrogio, Laura
Reed, Hasina Outtz
Funding for this research was provided by:
American Heart Association (834524)
National Institute of General Medical Sciences (1R35GM142835-01)
National Institute of Allergy and Infectious Diseases (R01AI137198)
National Heart, Lung, and Blood Institute (K01HL145365)
Robert Wood Johnson Foundation
Article History
Received: 27 October 2021
Accepted: 9 March 2022
First Online: 23 March 2022
Competing interests
: AMKC is a cofounder, stock holder, and serves on the Scientific Advisory Board for Proterris, which develops therapeutic uses for carbon monoxide. AMKC also has a use patent on CO.